4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Zymeworks Inc. (ZYME) operates in the Biotechnology industry and is headquartered in Middletown, United States with about 243 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, ZYME reported $106M in revenue and ($81M) in net income.
Zymeworks Inc., a biotechnology company, develops biotherapeutics for the treatment of cancer, inflammation, and autoimmune diseases.
Interactive charts & full statements → Open the ZYME valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $106M | $76M | $76M | $412M | — |
| Operating Income (EBIT) | ($92M) | ($120M) | ($138M) | $130M | — |
| Net Income | ($81M) | ($123M) | ($119M) | $124M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $2M | $2M | $28M | $49M | $27M | — |
| Operating Income (EBIT) | ($47M) | ($44M) | ($22M) | ($1M) | ($26M) | — |
| Net Income | ($44M) | ($41M) | ($20M) | $2M | ($23M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $346M | $463M | $581M | $649M | — |
| Total Liabilities | $78M | $124M | $116M | $156M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ZYME viewer.
About TickerBase · Data methodology & sources